Advancing towards a male contraceptive: A novel approach from an unexpected direction

Trends in Pharmacological Sciences

Volumn 24, Issue 7, 2003, Pages 326-328

  Robaire, Bernard ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHLOROHYDRIN; CARBOHYDRATE DERIVATIVE; GOSSYPOL; IMIDAZOLE DERIVATIVE; MALE CONTRACEPTIVE AGENT; MIGLUSTAT; ORAL CONTRACEPTIVE AGENT; SPHINGOLIPID; 1 DEOXYNOJIRIMYCIN; DRUG DERIVATIVE;

EPIDIDYMIS; GAUCHER DISEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOKALEMIA; MALE; MALE FERTILITY; NEUROTOXICITY; NONHUMAN; ORAL CONTRACEPTION; PRIORITY JOURNAL; REVIEW; SANDHOFF DISEASE; SPERMATOGENESIS; SPERMATOZOON MATURATION; SPERMATOZOON MOTILITY; ANIMAL; DRUG EFFECT; FEMALE; FERTILITY; MOUSE; NOTE; ORAL DRUG ADMINISTRATION; SPERMATOZOON COUNT; TESTIS;

1-DEOXYNOJIRIMYCIN; ADMINISTRATION, ORAL; ANIMALS; CONTRACEPTIVE AGENTS, MALE; FEMALE; FERTILITY; MALE; MICE; SPERM COUNT; TESTIS;

EID: 0042734626     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00141-X     Document Type: Short Survey

References (25)

1. Anderson R.A., et al. Male contraception. Endocr. Rev. 23:2002;735-762.
2. Turner T.T. Spermatozoa are exposed to a complex microenvironment as they traverse the epididymis. Ann. New York Acad. Sci. 637:1991;364-383.
3. Zirkin B.R., et al. Maintenance of advanced spermatogenic cells in the adult rat testis: quantitative relationship to testosterone concentration within the testis. Endocrinology. 124:1989;3043-3049.
4. Lobl T.J., et al. Contraceptive efficacy of testosterone-estradiol implants in male rhesus monkeys. Contraception. 27:1983;383-389.
5. van Houten M.E., et al. Differences in reproductive endocrinology between Asian men and Caucasian men. Asian J. Androl. 2:2000;13-20.
6. Ewing L.L., et al. Synergistic interaction of testosterone and oestradiol inhibits spermatogenesis in rats. Nature. 269:1977;409-411.
7. Kamischke A., et al. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. J. Clin. Endocrinol. Metab. 86:2001;303-309.
8. McLachlan R.I., et al. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men. J. Clin. Endocrinol. Metab. 87:2002;546-556.
9. Ramachandra S.G., et al. Effect of chronic administration of 7alpha-methyl-19-nortestosterone on serum testosterone, number of spermatozoa and fertility in adult male bonnet monkeys (Macaca radiata). Reproduction. 124:2002;301-309.
10. Jackson H., et al. Contraception for the male: problems with progress. Clin. Obstet. Gynaecol. 6:1979;129-155.
11. Liu, G.Z. et al. (1985) Trials of gossypol as a male contraceptive. In Gossypol: A Potential Contraceptive for Men (Segal, S., ed.), pp. 9-16, Plenum Publishers.
12. Zavos P.M., et al. The inhibitory effects of gossypol on human sperm motility characteristics: possible modes of reversibility of those effects. Tohoku J. Exp. Med. 179:1996;167-175.
13. Liu G.Z., et al. Effects of K salt or a potassium blocker on gossypol-related hypokalemia. Contraception. 37:1988;111-117.
14. Shi Y.L., et al. Ion-channels in human sperm membrane and contraceptive mechanisms of male antifertility compounds derived from Chinese traditional medicine. Acta Pharmacol. Sin. 24:2003;22-30.
15. Cheng C.Y., et al. Indazole carboxylic acids in male contraception. Contraception. 65:2002;265-268.
16. Cooper, T.G. (2002) The epididymis as a target for male contraception. In The Epididymis: From Molecules to Clinical Practice (Robaire, B. and Hinton, B.T., eds), pp. 483-502, Kluwer Academic Plenum Publishers.
17. Frayne J., et al. The potential use of sperm antigens as targets for immunocontraception; past, present and future. J. Reprod. Immunol. 43:1999;1-33.
18. Ren D., et al. A sperm ion channel required for sperm motility and male fertility. Nature. 413:2001;603-609.
19. van der Spoel A.C., et al. Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception. Proc. Natl. Acad. Sci. U. S. A. 99:2002;17173-17178.
20. Butters T.D., et al. Therapeutic applications of imino sugars in lysosomal storage disorders. Curr. Top. Med. Chem. 3:2003;561-574.
21. Platt F.M., et al. Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy. J. Inherit. Metab. Dis. 24:2001;275-290.
22. Cox T., et al. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet. 355:2000;1481-1485.
23. Trasler J., et al. Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides. Endocrinology. 139:1998;3280-3288.
24. Fujimoto H.K., et al. Requirement of seminolipid in spermatogenesis revealed by UDP-galactose: Ceramide galactosyltransferase-deficient mice. J. Biol. Chem. 275:2000;22623-22626.
25. White D., et al. Role of sperm sulfogalactosylglycerolipid in mouse sperm-zona pellucida binding. Biol. Reprod. 63:2000;147-155.